I appreciate your interest in Monogram. In our last webinar, we promised to mix things up and bring in an industry expert to ask us questions from an institutional perspective. We've delivered!
Matt Taylor, CFA Managing Director at UBS, has agreed to host us for a lively discussion about all things Ortho! We provide more details on Matt's credentials below, but as a headline, he leads US Medical Supplies and Devices equity research for UBS, a major investment bank and one of the largest private banks in the world. Matt and his team actively cover all the major ortho players in the space.
Matt has been following the Monogram story. We asked him to host a call for our community and ask us anything any knowledgeable ortho investor might ask or want to know; no holds barred.
The call will be on Thursday, 30 Sep 2021, at 10:00 AM EST. Register HERE
The discussion with Monogram's CEO Ben Sexson and CMO Doug Unis will be unscripted and include live audience Q&A.
Discussion Topics Include:
The current state of robotics with thoughts on solutions from the established players.
Monogram's solution and vision for differentiation in robotics.
Understanding Monograms cutting edge surgical tools and personalized implants.
Views on where robotics can go in Ortho in 5-10 years.
You can register here.
About Matt Taylor, CFA:
Matt Taylor is a Managing Director and leads coverage of US Medical Supplies and Devices equity research at UBS. Matt has received recognition for his work as a MedTech analyst, achieving a top-5 position and 'runner-up' ranking in the 2019 Institutional Investor poll and he was named an 'up-and-comer' in the 2011-13 surveys. Prior to joining UBS, Matt was the senior analyst covering Medical Supplies and Devices at Barclays, joining the organization as a senior associate in 2009. Matt also worked as an associate analyst in MedTech at BMO Capital Markets from 2007-2009 and began his career in finance working in a business risk role at Morgan Stanley. Matt was trained as a biomedical engineer and holds a BS in Biomedical Engineering from Boston University, an MBA from Fordham University, participating in the Beijing MBA program, and is a CFA Charterholder.
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
By attending this event, you understand and agree that your name, company name, and email address may be shared by UBS with the speaker(s) who led or participated in the sessions you attended. Please send an email to email@example.com<mailto:firstname.lastname@example.org> if you do not wish this to occur.
Notice to Public Officials/Government Employees: UBS seeks to comply with applicable laws, regulations and policies concerning the entertainment of public officials and government employees (including those of state-owned entities). Compliance with the rules applicable in your jurisdiction or to your agency is your responsibility, and we cannot advise you about such rules. If the rules or policies applicable to your agency allow you to participate in this event, and you would like to attend, please contact your UBS Salesperson for more information about our registration procedures. Please inform your UBS Salesperson if your agency's rules or policies require you to pay all or any part of the costs of attending this event, as alternative arrangements may need to be made. You will also be responsible for any reporting obligations to departments/agencies external to your agency.
When you receive UBS Access Invites (including, but not limited to, invitations to participate in UBS corporate access events, UBS analyst marketing events, UBS conferences, UBS field trips, UBS expert events, and the like) or are otherwise informed of the events et al. to which they relate, you agree not to copy, revise, amend, create a derivative work of, or in any way commercially exploit the UBS Access Invites. You further agree not to pass along, disclose or forward the UBS Access Invites, or information regarding the events et al. to which they relate, to any third party for any purpose, without the prior written consent of UBS. The foregoing restrictions on use apply to all UBS Access Invites that you may receive, irrespective of the means through which they are communicated to you.
This communication is issued by UBS AG and/or any of its subsidiaries and/or any of its affiliates ("UBS").
In the United States, this communication is issued by UBS Securities LLC (member NYSE, FINRA and SIPC) or by UBS Financial Services Inc. (member FINRA and SIPC), both of which are subsidiaries of UBS AG, or solely to US institutional investors by UBS AG or by a subsidiary or affiliate thereof that is not registered as a US broker-dealer (a "non-US affiliate"). Transactions resulting from a communication distributed by a non-US affiliate must be effected through UBS Securities LLC or UBS Financial Services Inc.
Neither UBS nor any of its directors, officers, employees or agents accepts any liability for any loss or damage arising out of the use of all or any part of this communication or reliance upon any information contained herein.
Intended for recipient only and not for further distribution without the consent of UBS.
Please inform UBS if your organization’s internal policies do not permit you to accept this invitation. UBS assumes otherwise that your participation at this event is in compliance with your organization’s policies and that any necessary internal notifications have been made by you.
Please apply the requisite security measures and take all reasonable steps in accordance with good industry practice to defend yourself against fraud or cyber-attacks, including, but not limited to updating your computer systems and security software on a continuous basis (e.g. by installing recommended security patches, observing customary technical security measures, in particular the installation of up-to-date firewalls and antivirus programs).
The use of e-mail can involve substantial risks - for example, information can be intercepted, corrupted, lost, destroyed, arrive late or be incomplete. E-mails can also contain corrupted files, viruses, links or other destructive or deceptive items that could harm or interfere with your computer or device. E-mails could also be sent by people who try to trick, mislead or deceive others into sharing information, particularly personal or financial information, under false pretenses. By allowing UBS to contact you by e-mail, you understand that communications sent via e-mail are not secure or error-free, and accept the risks that come with communicating with UBS via e-mail. You also accept and agree that UBS has no liability or responsibility for any loss or damage resulting from the use of e-mails or for any losses that you might suffer as a result of communicating with UBS via e-mail.
If you do not want to receive such communications by email please click unsubscribe and we will continue to send materials by post. If you would like to cease receiving all communications or have any requests please contact email@example.com<mailto:firstname.lastname@example.org>